Developing innovative biopharmacueticals for patients with neuropathic pain
Our lead candidate, HB-086 is in early preclinical development, and targets underserved neuropathic pain indications. The family of neurotrophic factors may prove beneficial in a varity of CNS disorders .
Neuropathic pain is caused by a lesion or disease of the somatosensory nervous system. Triggers include endocrine disorders, viral infections injury or nerve toxins (e.g. chemotherapy).
Degenerative nerve disorders are a broad spectrum of progressive diseases characterized by motor dysfunction, behavioral and personality changes and cognitive decline.
Hearing loss may be caused by a number of factors, including: genetics, ageing, exposure to noise, infections, trauma, and certain medications or toxins.
Our focus are